Krystal Biotech Inc (KRYS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.05B
Last updated: Nov 17, 2026 at 11:06 AM ET
Krystal Biotech Inc (KRYS) Competitors
The companies most similar to Krystal Biotech are BridgeBio Pharma (BBIO), Crispr Therapeutics AG (CRSP) and TG Therapeutics (TGTX). Krystal Biotech trades at 40.4x earnings, against a median of 39.6x for the 3 of these companies with a P/E. By market cap, Krystal Biotech ranks 7th of the 13 companies on this page; BridgeBio Pharma (BBIO) is the largest at $15.25B.
Peer Comparison
KRYS's revenue growth of 30.2% is below the peer median of 136.1%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Krystal Biotech (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| BridgeBio Pharma Inc (BBIO) | $15.25B | N/A | 16.0x | -59.8% | -33.0% | 192.6% | 0.00% |
| Crispr Therapeutics AG (CRSP) | $4.10B | N/A | 155.2x | 0.0% | -20.3% | 1325.0% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Bio-Techne Corp (TECH) | $11.44B | 39.6x | 9.3x | 14.0% | 7.7% | 4.6% | 0.44% |
| Kodiak Sciences Inc (KOD) | $7.27B | N/A | N/A | 0.0% | -1481.8% | 0.0% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Spyre Therapeutics Inc. (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Kymera Therapeutics Inc (KYMR) | $10.89B | N/A | 123.2x | 0.0% | N/A | 466.4% | 0.00% |
| Rhythm Pharmaceuticals Inc (RYTM) | $7.97B | N/A | 26.4x | -69.0% | -98.6% | 79.6% | 0.00% |
| Cytokinetics Inc (CYTK) | $7.82B | N/A | 65.3x | 0.0% | -66.0% | 2357.0% | 0.00% |
| Praxis Precision Medicines Inc (PRAX) | $9.17B | N/A | N/A | 0.0% | N/A | 1349.0% | 0.00% |
| PTC Therapeutics Inc (PTCT) | $5.30B | N/A | 5.2x | -9.2% | 18.1% | 69.6% | 0.00% |
| Peer median | $8.86B | 39.6x | 16.0x | 0.0% | -26.6% | 136.1% | 0.00% |
Similar Companies
These are the 12 companies most similar to Krystal Biotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| BridgeBio Pharma Inc (BBIO) | BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. | BBIO competitors |
| Crispr Therapeutics AG (CRSP) | CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. | CRSP competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Bio-Techne Corp (TECH) | Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments... | TECH competitors |
| Kodiak Sciences Inc (KOD) | Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing... | KOD competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Spyre Therapeutics Inc. (SYRE) | Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by... | SYRE competitors |
| Kymera Therapeutics Inc (KYMR) | Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down... | KYMR competitors |
| Rhythm Pharmaceuticals Inc (RYTM) | Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment... | RYTM competitors |
| Cytokinetics Inc (CYTK) | Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering... | CYTK competitors |
| Praxis Precision Medicines Inc (PRAX) | Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal... | PRAX competitors |
| PTC Therapeutics Inc (PTCT) | PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. | PTCT competitors |
Frequently Asked Questions About KRYS
Who are Krystal Biotech's main competitors?
The companies most similar to Krystal Biotech include BridgeBio Pharma (BBIO), Crispr Therapeutics AG (CRSP), TG Therapeutics (TGTX), Bio-Techne (TECH) and Kodiak Sciences (KOD), listed from the closest match.
Who is Krystal Biotech's biggest competitor?
BridgeBio Pharma (BBIO) is both the largest of the similar companies at $15.25B and the closest match by business profile, size, sector and industry.
How does KRYS stock compare with its competitors?
KRYS' P/E is 40.4x against a peer median of 39.6x; its P/S is 18.8x against a peer median of 16.0x; its net margin is 47.9% against a peer median of 0.0%.
Which of Krystal Biotech's competitors pays a higher dividend?
Krystal Biotech pays no dividend. Bio-Techne (TECH) has a higher forward dividend yield; Bio-Techne (TECH) has the highest at 0.44%.
Is Krystal Biotech bigger than its competitors?
No. Krystal Biotech is 7th by market cap among the 13 companies on this page; the largest is BridgeBio Pharma (BBIO) at $15.25B.
KRYS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors